168 related articles for article (PubMed ID: 8435988)
21. Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone.
Miyazaki Y; Mahankali A; Matsuda M; Glass L; Mahankali S; Ferrannini E; Cusi K; Mandarino LJ; DeFronzo RA
Diabetes Care; 2001 Apr; 24(4):710-9. PubMed ID: 11315836
[TBL] [Abstract][Full Text] [Related]
22. Long term improvement in insulin response with gliclazide treatment.
Bodansky HJ; Medback S; Cudworth AG; Rees LH; de Silva RS
Diabete Metab; 1982 Dec; 8(4):319-22. PubMed ID: 6761187
[TBL] [Abstract][Full Text] [Related]
23. Twice daily insulin therapy in patients with type 2 diabetes and secondary failure to sulphonylureas.
Wolffenbuttel BH; Weber RF; Weeks L; van Koetsveld PM; Verschoor L
Diabetes Res; 1990 Feb; 13(2):79-84. PubMed ID: 2091874
[TBL] [Abstract][Full Text] [Related]
24. Safety and efficacy of normalizing fasting glucose with bedtime NPH insulin alone in NIDDM.
Cusi K; Cunningham GR; Comstock JP
Diabetes Care; 1995 Jun; 18(6):843-51. PubMed ID: 7555511
[TBL] [Abstract][Full Text] [Related]
25. Metabolic effects of metformin addition to chronic glibenclamide treatment in type 2 diabetes.
Marena S; Tagliaferro V; Montegrosso G; Pagano A; Scaglione L; Pagano G
Diabete Metab; 1994; 20(1):15-9. PubMed ID: 8056129
[TBL] [Abstract][Full Text] [Related]
26. Whole-body glucose metabolism in obese patients with type 2 diabetes mellitus: the impact of hypertension and strict blood glucose control.
Vestergaard H; Parving HH; Hansen L; Pedersen O
Diabet Med; 1995 Feb; 12(2):156-63. PubMed ID: 7743763
[TBL] [Abstract][Full Text] [Related]
27. Contribution of obesity to defects of intracellular glucose metabolism in NIDDM.
Chung JW; Suh KI; Joyce M; Ditzler T; Henry RR
Diabetes Care; 1995 May; 18(5):666-73. PubMed ID: 8586004
[TBL] [Abstract][Full Text] [Related]
28. Effect of metformin on peripheral insulin sensitivity in non insulin dependent diabetes mellitus.
Prager R; Schernthaner G; Graf H
Diabete Metab; 1986 Dec; 12(6):346-50. PubMed ID: 3817257
[TBL] [Abstract][Full Text] [Related]
29. Long-term efficacy and tolerability of add-on pioglitazone therapy to failing monotherapy compared with addition of gliclazide or metformin in patients with type 2 diabetes.
Charbonnel B; Schernthaner G; Brunetti P; Matthews DR; Urquhart R; Tan MH; Hanefeld M
Diabetologia; 2005 Jun; 48(6):1093-104. PubMed ID: 15889234
[TBL] [Abstract][Full Text] [Related]
30. Acarbose improves indirectly both insulin resistance and secretion in obese type 2 diabetic patients.
Delgado H; Lehmann T; Bobbioni-Harsch E; Ybarra J; Golay A
Diabetes Metab; 2002 Jun; 28(3):195-200. PubMed ID: 12149599
[TBL] [Abstract][Full Text] [Related]
31. Effect of metformin on insulin-stimulated glucose turnover and insulin binding to receptors in type II diabetes.
Nosadini R; Avogaro A; Trevisan R; Valerio A; Tessari P; Duner E; Tiengo A; Velussi M; Del Prato S; De Kreutzenberg S
Diabetes Care; 1987; 10(1):62-7. PubMed ID: 3552515
[TBL] [Abstract][Full Text] [Related]
32. United Kingdom Prospective Diabetes Study (UKPDS). 13: Relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years.
BMJ; 1995 Jan; 310(6972):83-8. PubMed ID: 7833731
[TBL] [Abstract][Full Text] [Related]
33. Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus.
Vaag A; Henriksen JE; Madsbad S; Holm N; Beck-Nielsen H
J Clin Invest; 1995 Feb; 95(2):690-8. PubMed ID: 7860750
[TBL] [Abstract][Full Text] [Related]
34. Effects of benfluorex on insulin resistance and lipid metabolism in obese type II diabetic patients.
Bianchi R; Bongers V; Bravenboer B; Erkelens DW
Diabetes Care; 1993 Apr; 16(4):557-9. PubMed ID: 8462377
[TBL] [Abstract][Full Text] [Related]
35. Insulin action in black Americans with NIDDM.
Banerji MA; Lebovitz HE
Diabetes Care; 1992 Oct; 15(10):1295-302. PubMed ID: 1425092
[TBL] [Abstract][Full Text] [Related]
36. Acute hyperinsulinaemia decreases cholesterol synthesis less in subjects with non-insulin-dependent diabetes mellitus than in non-diabetic subjects.
Naoumova RP; Cummings MH; Watts GF; Rendell NB; Taylor GW; Sönksen PH; Thompson GR
Eur J Clin Invest; 1996 Apr; 26(4):332-40. PubMed ID: 8732493
[TBL] [Abstract][Full Text] [Related]
37. Normalization of fasting glycaemia by intravenous GLP-1 ([7-36 amide] or [7-37]) in type 2 diabetic patients.
Nauck MA; Weber I; Bach I; Richter S; Orskov C; Holst JJ; Schmiegel W
Diabet Med; 1998 Nov; 15(11):937-45. PubMed ID: 9827848
[TBL] [Abstract][Full Text] [Related]
38. Improvement of insulin-induced glucose disposal in obese patients with NIDDM after 1-wk treatment with d-fenfluramine.
Scheen AJ; Paolisso G; Salvatore T; Lefèbvre PJ
Diabetes Care; 1991 Apr; 14(4):325-32. PubMed ID: 2060435
[TBL] [Abstract][Full Text] [Related]
39. Metabolic alterations in middle-aged and elderly obese patients with type 2 diabetes.
Meneilly GS; Elliott T
Diabetes Care; 1999 Jan; 22(1):112-8. PubMed ID: 10333911
[TBL] [Abstract][Full Text] [Related]
40. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.
DeFronzo RA; Barzilai N; Simonson DC
J Clin Endocrinol Metab; 1991 Dec; 73(6):1294-301. PubMed ID: 1955512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
